Endpoints for Lymphatic Filariasis Programs

In 2000, annual mass administration of diethlycarbamazine and albendazole began in Leogane Commune, Haiti, to interrupt transmission of lymphatic filariasis (LF). After 5 years of treatment, microfilaremia, antigenemia, and mosquito infection rates were significantly reduced, but LF transmission was...

Descripción completa

Detalles Bibliográficos
Autores principales: Grady, Caroline A., Beau de Rochars, Madsen, Direny, Abdel N., Orelus, Jean Nicolas, Wendt, Joyanna, Radday, Jeanne, Mathieu, Els, Roberts, Jacquelin M., Streit, Thomas G., Addiss, David G., Lammie, Patrick J.
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2007
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725965/
https://www.ncbi.nlm.nih.gov/pubmed/17553278
http://dx.doi.org/10.3201/eid1304.061063
Descripción
Sumario:In 2000, annual mass administration of diethlycarbamazine and albendazole began in Leogane Commune, Haiti, to interrupt transmission of lymphatic filariasis (LF). After 5 years of treatment, microfilaremia, antigenemia, and mosquito infection rates were significantly reduced, but LF transmission was not interrupted. These finding have implications for other LF elimination programs.

Ejemplares similares